A trial to evaluate the effect of delayed-release dimethyl fumarate (DMF), on the pharmacokinetics (PK) of a commonly used oral contraceptive (OC; Ethinylestradiol/norgestimate) in healthy women: An open-label, randomised, crossover study
Latest Information Update: 24 Nov 2017
Price :
$35 *
At a glance
- Drugs Dimethyl fumarate (Primary) ; Ethinylestradiol/norgestimate
- Indications Multiple sclerosis
- Focus Pharmacokinetics
- Sponsors Biogen
- 01 Dec 2017 Results published in the Clinical Pharmacology in Drug Development
- 03 May 2016 New trial record
- 21 Apr 2016 Results presented at the 68th Annual Meeting of the American Academy of Neurology